Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

eastman chemical co. - EMN

EMN

Close Chg Chg %
76.09 1.32 1.73%

Closed Market

77.41

+1.32 (1.73%)

Volume: 1.31M

Last Updated:

Feb 6, 2026, 3:59 PM EDT

Trade Now

Company Overview: eastman chemical co. - EMN

EMN Key Data

Open

$76.39

 Day Range

76.39 - 78.09

52 Week Range

56.12 - 103.82

 Market Cap

$8.95B

Shares Outstanding

114.07M

 Public Float

113.23M

Beta

1.25

 Rev. Per Employee

N/A

P/E Ratio

18.56

 EPS

$4.13

Yield

437.70%

 Dividend

$0.84

EX-DIVIDEND DATE

Dec 15, 2025

 SHORT INTEREST

N/A

AVERAGE VOLUME

1.93M

  

EMN Performance

1 Week
 
 11.70%
 
1 Month
 
 12.61%
 
3 Months
 
 26.42%
 
1 Year
 
 -21.96%
 
5 Years
 
 -25.90%
 

EMN Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 20
Full Ratings ➔

About eastman chemical co. - EMN

Eastman Chemical Co. engages in the provision of specialty chemicals. It operates through the following segments: Advanced Material (AM), Additives and Functional Products (AFP), Chemical Intermediates (CI), and Fibers. The AM segment produces and markets its polymers, films, and plastics with differentiated performance properties for value-added end uses in transportation, consumables, building and construction, durable goods, and health and wellness markets. The AFP segment includes chemicals for products in the transportation, consumables, building and construction, animal nutrition, crop protection, energy, personal and home care, and other markets. The CI segment consists of large scale and vertical integration from the cellulose and acetyl, olefins, and alkylamines streams to support operating segments with advantaged cost positions. The Fibers segment offers cellulose acetate tow for use in filtration media, primarily cigarette filters. The company was founded by George Eastman in 1920 and is headquartered in Kingsport, TN.

EMN At a Glance

Eastman Chemical Co.
200 South Wilcox Drive
Kingsport, Tennessee 37662
Phone 1-800-327-8626 Revenue 8.75B
Industry Chemicals: Specialty Net Income 474.00M
Sector Process Industries Employees N/A
Fiscal Year-end 12 / 2026
View SEC Filings

EMN Valuation

P/E Current 18.556
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 15.568
Price to Sales Ratio 0.843
Price to Book Ratio N/A
Price to Cash Flow Ratio 7.61
Enterprise Value to EBITDA N/A
Enterprise Value to Sales N/A
Total Debt to Enterprise Value N/A

EMN Efficiency

Revenue/Employee N/A
Income Per Employee N/A
Receivables Turnover N/A
Total Asset Turnover N/A

EMN Liquidity

Current Ratio N/A
Quick Ratio N/A
Cash Ratio N/A

EMN Profitability

Gross Margin 21.069
Operating Margin 10.638
Pretax Margin 6.49
Net Margin 5.416
Return on Assets N/A
Return on Equity N/A
Return on Total Capital N/A
Return on Invested Capital N/A

EMN Capital Structure

Total Debt to Total Equity N/A
Total Debt to Total Capital N/A
Total Debt to Total Assets N/A
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital N/A
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Eastman Chemical Co. - EMN

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
10.54B 9.20B 9.37B 8.75B
Sales Growth
+0.50% -12.69% +1.91% -6.64%
Cost of Goods Sold (COGS) incl D&A
8.48B 7.14B 7.04B 6.91B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
477.00M 498.00M 509.00M 513.00M
Depreciation
- 390.00M 412.00M 427.00M
Amortization of Intangibles
- 87.00M 86.00M 82.00M
COGS Growth
+6.45% -15.84% -1.29% -1.93%
Gross Income
2.06B 2.06B 2.33B 1.84B
Gross Income Growth
-18.35% +0.29% +13.00% -20.86%
Gross Profit Margin
+19.52% +22.42% +24.86% +21.07%
2022 2023 2024 2025 5-year trend
SG&A Expense
972.00M 966.00M 986.00M 913.00M
Research & Development
264.00M 239.00M 250.00M 255.00M
Other SG&A
708.00M 727.00M 736.00M 658.00M
SGA Growth
-7.34% -0.62% +2.07% -7.40%
Other Operating Expense
- - - -
-
Unusual Expense
81.00M 65.00M 73.00M 96.00M
EBIT after Unusual Expense
1.00B 1.03B 1.27B 835.00M
Non Operating Income/Expense
156.00M 278.00M 20.00M (59.00M)
Non-Operating Interest Income
- 6.00M 10.00M 16.00M
Equity in Earnings of Affiliates
- - 19.00M 10.00M
-
Interest Expense
182.00M 222.00M 213.00M 208.00M
Interest Expense Growth
-5.21% +21.98% -4.05% -2.35%
Gross Interest Expense
191.00M 240.00M 230.00M 208.00M
Interest Capitalized
- 9.00M 18.00M 17.00M
Pretax Income
977.00M 1.09B 1.08B 568.00M
Pretax Income Growth
-9.70% +11.26% -0.83% -47.31%
Pretax Margin
+9.27% +11.82% +11.50% +6.49%
Income Tax
181.00M 191.00M 170.00M 93.00M
Income Tax - Current - Domestic
- 212.00M 140.00M 46.00M
Income Tax - Current - Foreign
- 105.00M 153.00M 176.00M
Income Tax - Deferred - Domestic
- (126.00M) (67.00M) (93.00M)
Income Tax - Deferred - Foreign
- (10.00M) (35.00M) 41.00M
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - 19.00M 10.00M
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
796.00M 896.00M 908.00M 475.00M
Minority Interest Expense
3.00M 2.00M 3.00M 1.00M
Net Income
793.00M 894.00M 905.00M 474.00M
Net Income Growth
-7.47% +12.74% +1.23% -47.62%
Net Margin Growth
+7.53% +9.72% +9.65% +5.42%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
793.00M 894.00M 905.00M 474.00M
Preferred Dividends
- - - -
-
Net Income Available to Common
793.00M 894.00M 905.00M 474.00M
EPS (Basic)
6.421 7.5379 7.7549 4.1325
EPS (Basic) Growth
+1.07% +17.39% +2.88% -46.71%
Basic Shares Outstanding
123.50M 118.60M 116.70M 114.70M
EPS (Diluted)
6.3491 7.4874 7.676 4.1
EPS (Diluted) Growth
+1.57% +17.93% +2.52% -46.59%
Diluted Shares Outstanding
124.90M 119.40M 117.90M 115.60M
EBITDA
1.56B 1.59B 1.85B 1.44B
EBITDA Growth
-22.22% +2.11% +16.25% -22.07%
EBITDA Margin
+14.82% +17.33% +19.77% +16.50%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 73.313
Number of Ratings 20 Current Quarters Estimate 1.128
FY Report Date 03 / 2026 Current Year's Estimate 5.851
Last Quarter’s Earnings 0.75 Median PE on CY Estimate N/A
Year Ago Earnings 5.42 Next Fiscal Year Estimate 6.702
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 15 15 16 14
Mean Estimate 1.13 1.63 5.85 6.70
High Estimates 1.22 1.91 6.16 7.00
Low Estimate 1.07 1.50 5.55 6.45
Coefficient of Variance 3.47 6.72 3.22 2.84

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 9 9 13
OVERWEIGHT 2 2 1
HOLD 9 9 7
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Eastman Chemical Co. - EMN

Date Name Shares Transaction Value
Jan 7, 2026 Stephen G. Crawford EVP, Technology Projects 34,193 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Aug 29, 2025 Mark J. Costa CEO & Board Chair; Director 453,986 Open market or private purchase of non-derivative security Non-derivative transaction at $67.89 per share 30,821,109.54
Aug 29, 2025 Julie A. McAlindon SVP, Regions & Chf SupChn Ofcr 12,731 Open market or private purchase of non-derivative security Non-derivative transaction at $68.43 per share 871,182.33
Aug 29, 2025 William T. McLain EVP, CFO 53,524 Open market or private purchase of non-derivative security Non-derivative transaction at $68.73 per share 3,678,704.52
Aug 29, 2025 Brad A. Lich EVP & CCO 83,487 Open market or private purchase of non-derivative security Non-derivative transaction at $68.49 per share 5,718,024.63
Mar 6, 2025 Michelle Caveness SVP & Chf. Mfg. Ofc. 1,167 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $98.51 per share 114,961.17
Mar 6, 2025 Michelle Caveness SVP & Chf. Mfg. Ofc. 2,314 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $83.84 per share 194,005.76
Mar 6, 2025 Michelle Caveness SVP & Chf. Mfg. Ofc. 1,148 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 3, 2025 Mark J. Costa CEO & Board Chair; Director 446,586 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $100.08 per share 44,694,326.88
Mar 3, 2025 Mark J. Costa CEO & Board Chair; Director 48,649 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 21, 2025 Brad A. Lich EVP & CCO 81,957 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $103.47 per share 8,480,090.79
Feb 21, 2025 Stephen G. Crawford EVP-Methan. Ops & WWEC Transf. 58,912 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $103.47 per share 6,095,624.64
Feb 21, 2025 Julie A. McAlindon SVP, Regions & Chf SupChn Ofcr 10,731 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $103.47 per share 1,110,336.57
Feb 21, 2025 William T. McLain EVP, CFO 49,854 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $103.47 per share 5,158,393.38
Feb 21, 2025 Christopher M. Killian SVP, CTO & Sust. Ofc, 24,248 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 21, 2025 Christopher M. Killian SVP, CTO & Sust. Ofc, 21,038 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $103.47 per share 2,176,801.86
Feb 21, 2025 Michelle R. Stewart Controller & CAO 6,215 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 21, 2025 Michelle R. Stewart Controller & CAO 4,963 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $103.47 per share 513,521.61
Feb 21, 2025 Brian Travis Smith EVP, AFP, Mfg., WWEC & HSE 16,215 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 21, 2025 Adrian J. Holt SVP, Chf HR Ofcr 2,037 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $103.47 per share 210,768.39

Eastman Chemical Co. in the News